Archive for Regulatory & Marketplace v1i3
Patients first: Shifts in industry thinking
The patient is receiving more and more attention from the pharmaceutical industry. Although the physician was the centre of [...]
Read More →The introduction of targeted Medicines Use Reviews and the New Medicine Service in England
Statistics released from the Information Centre have shown a 70 per cent increase in prescription items dispensed in England [...]
Read More →Risk Mitigation Regulation in the U.S.
Prior to the implementation of REMS regulations, the FDA removed from the market many drugs that could benefit patients [...]
Read More →New medical software design standards
There are now regulations that govern the development of software that could be classified as a medical device. It’s [...]
Read More →Loading images...
Loading images...
Loading images...
IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.
Journal for Clinical Studies (JCS) is a peer reviewed journal which details practical and theoretical operational procedures, challenges, validatory and regulatory guidelines when conducting trials on a multisite basis and particularly within emerging markets, naïve patient population and remote access areas. JCS provides country by country objectives and uniquely brings you experiences in therapeutic areas prevalent in emerging market areas.
